Construction of a der p2-transgenic plant for the alleviation of airway inflammation

Cellular and Molecular Immunology

Volumn 8, Issue 5, 2011, Pages 404-414

  Lee, C C ^a   Ho, H ^b   Lee, K T ^c   Jeng, S T ^d   Chiang, B L ^b,e,f,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Institute of Microbiology and Biochemistry   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e Allergy Center   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g Graduate Institute of Clinical Medicine   (Taiwan)

Author keywords

asthma; Der p2; IL 10; oral tolerance; transgenic plant

Indexed keywords

DERMATOPHAGOIDES PTERONYSSINUS 2 ANTIGEN; EOTAXIN; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; FEMALE; LUNG LAVAGE; MEDIASTINUM LYMPH NODE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PLANT LEAF; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SPLEEN CELL; TOBACCO; TRANSGENIC PLANT;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-5; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; PLASMIDS; T-LYMPHOCYTES, REGULATORY; TRANSFECTION;

DERMATOPHAGOIDES PTERONYSSINUS; MUS; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

EID: 80052516050     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.13     Document Type: Article

References (35)

1. Beasley R. The burden of asthma with specific reference to the United States. J Allergy Clin Immunol 2002; 109: S482-S489 (Pubitemid 34499500)
2. +T cells in brown Norway rats. J Clin Invest 1995; 96: 1303-1310.
3. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304
4. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-507
5. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005; 206: 232-259 (Pubitemid 41105174)
6. Chen Y. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177-180.
7. Mcmenamin C, Mckersey M, Kuhnlein P, Hunig T, Holt PG.Gammadelta T cells downregulate primary IgE responses I rats toinhaled soluble protein antigens. J Immunol 1995; 154: 4390-4394
8. van Houten N, Blank SF. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 1996; 157: 1337-1341 (Pubitemid 126449069)
9. + regulatory T cells by oral antigen administration. J Immunol 2001; 167: 4245-4253 (Pubitemid 32954298)
10. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol 2003; 111: S712-S719
11. Passalacqua G, Baena-Cagnani CE, Berardi M, Canonica GW. Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol 2003; 3: 139-145 (Pubitemid 36529505)
12. La Rosa M, Ranno C, André C, Carat F, Tosca MA, CanonicaGW. Double-blind placebocontrolled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999; 104: 425-432 (Pubitemid 29420442)
13. Giovane AL, Bardare M, Passalacqua G, Ruffoni S, Scordamaglia A, Ghezzi E et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994; 24: 53-59 (Pubitemid 24210816)
14. Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003; 33: 206-210. (Pubitemid 36241378)
15. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-448 (Pubitemid 36337857)
16. Peden DB, Bush RK. Advances in environmental and occupational respiratory disease in 2010 J Allergy Clin Immunol 2011; 127: 696-700.
17. Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY et al. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 1997; 3: 793-796 (Pubitemid 27298727)
18. Hamelmann E, Schwarze J, Takeda A, Oshiba A, Larsen GL, Irvin CG et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care 1997; 156: 766-775 (Pubitemid 27396413)
19. GlA-Ab T, Mitzner W, Braun A, Ernst H, Hohllfeld JM, Krug N et al. Repetitive measurements of pulmonary mechanics to inhaled cholinergic challenge in spontaneously breathing mice. J Appl Physiol 2004; 97: 1104-1111 (Pubitemid 39121439)
20. Jobling SA, Gehrke L. Enhanced translation of chimaeric messenger RNAs containing a plant viral untranslated leader sequence. Nature 1987; 325: 622-625 (Pubitemid 17055684)
21. Matsuoka K, Nakamura K. Propeptide of a precursor to a plant vacuolar protein required for vacuolar targeting. Proc Natl Acad Sci USA 1991; 88: 834-838 (Pubitemid 21916118)
22. Tsai JJ, Liu YH, Shen HD, Huang SH, Han SH. Prevention of Der p2-induced allergic airway inflammation by Mycobacterium-bacillus Calmette Guerin. J Arch Allergy Immunol 2002; 121: 205-210.
23. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Betten F et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101: 747-754
24. + T cells precedes the development of tolerance in vivo. Int immunol 1996; 8: 335-342 (Pubitemid 26070933)
25. Mastrandrea F, Serio G, Minardi A, Coradduzza G, Rossi N, Scarcia G et al. IgE responses to Dermatophagoides pteronyssinus native major allergens Der p 1 and Der p 2 during long-term specific immunotherapy. Allergy 1997 52: 1115-1119 (Pubitemid 27496260)
26. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ. Adaptive Foxp31 regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008; 29: 114-126
27. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8: 523-532
28. Pretolani M. Interleukin-10: an anti-inflammatory cytokine with therapeutic potential. Clin Exp Allergy 1999; 29: 1164-1171 (Pubitemid 29406463)
29. Saraiva M, O'Garra A. The regulation of IL10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181
30. Moore KW, de WA-Al Malefyt R, Coffman RL, O'Garra A. Interleukin10 and the interleukin10 receptor. Annu Rev Immunol 2001; 19: 683-765
31. + T cell dependent immune deviation resulting in selective suppression of immunoglobin E production. J Exp Med 1993; 178: 889-899 (Pubitemid 23260426)
32. Daniell H. SS, Wyeoff K. Medical molecular farming: production of antibodies, biopharmaceuticals, and edible vaccines in plants. Trends Plant Sci 2001; 6: 219
33. Cretico PS. Immunotherapy with allergens. J Am Med Assoc 1992; 268: 2834
34. Mor TS, Gómez-Lim MA, Palmer KE. Perspective: edible vaccines-a concept coming of age. Trends Microbiol 1998; 6: 449-453 (Pubitemid 28543238)
35. Kusnadi AR, Nikolov ZL, Howard JA. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 1997; 3: 793-796